KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma

KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma

BackgroundThe incidence and mortality of uterine corpus endometrial carcinoma (UCEC) are increasing yearly. There is currently no screening test for UCEC, and progress in its treatment is limited. It is important to identify new biomarkers for screening, diagnosing and predicting the outcomes of UCE...

Full description

Bibliographic Details
Main Authors: Kang He, Jingze Li, Xuemiao Huang, Weixin Zhao, Kai Wang, Taiwei Wang, Junyu Chen, Zeyu Wang, Jiang Yi, Shuhua Zhao, Lijing Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
KNL1
uterine corpus endometrial carcinoma
bioinformatics
prognosis
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1090779/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1090779/full

Similar Items